Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 09, 2021
Intravascular Large B Cell Lymphoma as a Cause of Multifocal Cryptogenic Stroke.
Journal: The American journal of medicine
Published: March 01, 2021
Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition.
Journal: Journal for immunotherapy of cancer
Published: September 04, 2019
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.
Journal: Journal for immunotherapy of cancer
Published: September 14, 2018
Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?
Journal: Journal of digital imaging
Published: November 25, 2015
Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST.
Journal: BMC cancer
Published: October 28, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026